Tregs and MDSCs could favor tumor immune escape in NAFLD, as they have been shown to exert immunosuppressive effects on CD8+ T cells and NK cells in NASH (161). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.